Form 4 for GALT GALECTIN THERAPEUTICS INC
Accepted 2024-10-17 00:00:00 ET · period of report 2024-10-17 · accession 0001133416-24-000058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-17 | 2024-10-17 | GALT | FREEMAN KEVIN D | Dir | P - Purchase | $2.64 | +1,300 | 34.8K | +4% | +$3,432 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-17 | P | A | 1,300 | $2.64 | 34,769 | D | — | — |